Command Palette

Search for a command to run...

kerala-ayurveda

442-1.33%
Market Cap
₹538.99 Cr
Stock P/E
-41.39
ROCE
6.75%
ROE
-5.44%
Book Value
₹14.03

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Laggard

Kerala Ayurveda Ltd. lags significantly behind its peers in several key financial metrics, particularly in profitability with negative EPS and ROE, and high debt levels. The company’s growth prospects are overshadowed by its poor financial health, making it a less attractive option compared to its sector peers who display stronger profitability and robust financial structures.

Key Points
  • Kerala Ayurveda Ltd. shows negative EPS and ROE, indicating poor profitability.
  • High debt-equity ratio at 2.40 suggests financial risk compared to peers.
  • Growth metrics are decent but overshadowed by profitability concerns.
Top Performers
Dr. Reddy's Laboratories Ltd.

Highest profitability with strong EPS and ROE.

Cipla Ltd.

Strong balance sheet with low debt and solid growth metrics.

Mankind Pharma Ltd.

Outstanding revenue growth and solid margins.

Sun Pharmaceutical Industries Ltd.

Strong profitability metrics despite high PE.

Torrent Pharmaceuticals Ltd.

Balanced approach with good profitability and manageable debt.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.